We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Vera Bradley
VRA
$98.7M
| $1.15M | ﹤0.01% |
169,209
+73,269
| +76% | +$537K |
|
1827
Agilon Health
AGL
$1.6B
| $1.15M | ﹤0.01% |
+7,531
| New | +$1.25M |
|
1828
Phibro Animal Health
PAHC
$1.39B
| $1.15M | ﹤0.01% |
88,767
-1,343
| -1% | -$16.1K |
|
|
LOMA
1829
Loma Negra
LOMA
$1.22B
| $1.15M | ﹤0.01% |
171,475
-30,403
| -15% | -$206K |
|
1830
Tompkins Financial
TMP
$1.42B
| $1.14M | ﹤0.01% |
22,743
+12,756
| +128% | +$647K |
|
1831
Eastern Bankshares
EBC
$5.23B
| $1.14M | ﹤0.01% |
82,959
| – | – |
|
|
LYRA
1832
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $1.14M | ﹤0.01% |
3,675
+1,023
| +39% | +$273K |
|
|
DADA
1833
DELISTED
Dada Nexus
DADA
| $1.14M | ﹤0.01% |
+557,171
| New | +$1.19M |
|
1834
Wyndham Hotels & Resorts
WH
$5.48B
| $1.14M | ﹤0.01% |
+14,878
| New | +$1.17M |
|
1835
WhiteHorse Finance
WHF
$146M
| $1.14M | ﹤0.01% |
92,065
-5,578
| -6% | -$70.3K |
|
1836
Comfort Systems
FIX
$59.6B
| $1.14M | ﹤0.01% |
3,592
-7,808
| -68% | -$1.99M |
|
1837
Meritage Homes
MTH
$4.86B
| $1.14M | ﹤0.01% |
+13,000
| New | +$1.05M |
|
1838
Dianthus Therapeutics
DNTH
$6.09B
| $1.14M | ﹤0.01% |
+37,971
| New | +$825K |
|
1839
Texas Capital Bancshares
TCBI
$4.32B
| $1.14M | ﹤0.01% |
+18,445
| New | +$1.12M |
|
1840
NWPX Infrastructure Inc
NWPX
$1.15B
| $1.13M | ﹤0.01% |
32,685
-3,771
| -10% | -$116K |
|
|
NFBK
1841
DELISTED
Northfield Bancorp
NFBK
| $1.13M | ﹤0.01% |
116,127
+75,005
| +182% | +$822K |
|
1842
Origin Bancorp
OBK
$1.66B
| $1.13M | ﹤0.01% |
+36,085
| New | +$1.12M |
|
1843
Dow Inc
DOW
$21.2B
| $1.12M | ﹤0.01% |
19,399
-7,101
| -27% | -$392K |
|
|
MSB
1844
Mesabi Trust
MSB
$306M
| $1.12M | ﹤0.01% |
63,480
+22,741
| +56% | +$431K |
|
1845
John B. Sanfilippo & Son
JBSS
$972M
| $1.12M | ﹤0.01% |
10,597
+4,959
| +88% | +$512K |
|
|
AKRO
1846
DELISTED
Akero Therapeutics
AKRO
| $1.12M | ﹤0.01% |
+44,287
| New | +$1.06M |
|
1847
STAG Industrial
STAG
$7.19B
| $1.12M | ﹤0.01% |
29,055
+5,115
| +21% | +$194K |
|
1848
Archrock
AROC
$5.8B
| $1.12M | ﹤0.01% |
56,759
+16,026
| +39% | +$274K |
|
1849
Enterprise Financial Services Corp
EFSC
$2.39B
| $1.11M | ﹤0.01% |
27,470
+3,663
| +15% | +$150K |
|
1850
Hingham Institution for Saving
HIFS
$663M
| $1.11M | ﹤0.01% |
6,385
-900
| -12% | -$158K |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.